List view / Grid view
27 June 2016 | By Victoria White, Digital Content Producer
Scientists have identified a protein, called GlyRS, that launches cancer growth and appears to contribute to higher mortality in breast cancer patients...
13 June 2016 | By Victoria White, Digital Content Producer
Results from a study showed that JQ1 slowed tumour growth and limited the number of blood vessels that were produced...
3 June 2016 | By Victoria White, Digital Content Producer
Scientists have now discovered an effective solution to switch off all signals emanating from HER2 in breast cancer cells at the same time...
2 June 2016 | By Victoria White, Digital Content Producer
Fasnall appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the treatment of a host of cancers...
26 May 2016 | By Victoria White, Digital Content Producer
Scientists have completed the first large-scale proteogenomic study of breast cancer, linking DNA mutations to protein signalling...
25 May 2016 | By Victoria White, Digital Content Producer
Scientists have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from therapies...
13 May 2016 | By Victoria White, Digital Content Producer
Scientists also found that inhibiting oestrogen synthesis just after seizure onset strongly suppressed seizures in both sexes...
12 May 2016 | By Victoria White, Digital Content Producer
Dr Andrei Goga of UC San Francisco has taken a multi-faceted approach to identifying new therapeutic targets in MYC-driven triple-negative breast cancers...
11 May 2016 | By Victoria White, Digital Content Producer
Pfizer has awarded a total of more than $1 million in funding to five leading advocacy organisations to support metastatic breast cancer scientific research...
10 May 2016 | By Victoria White, Digital Content Producer
Scientists have designed a drug candidate, Targaprimir-96, that decreases the growth of tumour cells in animal models of triple negative breast cancer...
3 May 2016 | By Victoria White, Digital Content Producer
Scientists have shown how small structural changes in a key breast cancer receptor can produce predictable effects in curbing or accelerating cancer growth...
20 April 2016 | By Victoria White, Digital Content Producer
Emergent BioSolutions' ES425 molecule is being developed as a potential therapeutic for triple-negative breast cancer (TNBC)...
12 April 2016 | By Victoria White, Digital Content Producer
The discovery means that a family history of DCIS could be as important to assessing a woman’s risk as a history of invasive breast cancer...
7 March 2016 | By Victoria White
Scientists have provided a deeper insight into how BRCA1 functions in normal breast tissue and how its loss results in breast cancer...
9 February 2016 | By Victoria White
The programme aims to bring together breast cancer researchers and pharmaceutical companies to pool resources and stop women dying from breast cancer by 2050...
